Hansen S, Hupp T R, Lane D P
Department of Biochemistry, Medical Sciences Institute, The University of Dundee, Dundee, Scotland.
J Biol Chem. 1996 Feb 16;271(7):3917-24. doi: 10.1074/jbc.271.7.3917.
Conformational stability is a prerequisite for the physiological activity of the tumor suppressor protein p53. p53 protein can be allosterically activated for DNA binding by phosphorylation or through noncovalent interaction with proteins such as DnaK, the Escherichia coli homologue of the heat shock protein Hsp70. We present in vitro evidence for a rapid temperature-dependent change in the conformation and tetrameric nature of wild-type p53 upon incubation at 37 degrees C, which correlates with a permanent loss in DNA binding activity. We show that p53 is allosterically regulated for stabilization of the wild-type conformation and DNA binding activity at 37 degrees C by binding of two classes of ligands to regulatory sites on the N and C terminus of the molecule through which an intrinsic instability of p53 is neutralized. Deletion of the domain conferring instability at the C terminus is sufficient to confer enhanced stability to the total protein. DnaK binding to the C terminus can profoundly protect p53 at 37 degrees C from a temperature-dependent loss of the DNA binding activity but does not renature or activate denatured p53. In contrast, another activator of the DNA binding activity of latent p53, the monoclonal antibody PAb421, which also interacts with the C terminus of the protein, is not able to protect p53 from thermal denaturation. Two monoclonal antibodies to the N terminus of p53, PAb1801 and DO-1, do not activate the latent DNA binding function of p53 but can protect the p53 wild-type conformation at 37 degrees C. Thus, activation of the DNA binding function of p53 is not synonymous with protection from thermal denaturation, and therefore, both of these pathways may be used in cells to control the physiological activity of p53. The protection of p53 conformation from heat denaturation by interacting proteins suggests a novel mechanism by which p53 function could be regulated in vivo.
构象稳定性是肿瘤抑制蛋白p53生理活性的前提条件。p53蛋白可通过磷酸化或与诸如DnaK(热休克蛋白Hsp70的大肠杆菌同源物)等蛋白质的非共价相互作用而被变构激活以进行DNA结合。我们提供了体外证据,证明野生型p53在37℃孵育时其构象和四聚体性质会发生快速的温度依赖性变化,这与DNA结合活性的永久性丧失相关。我们表明,通过两类配体与分子N端和C端的调节位点结合,p53在37℃时被变构调节以稳定野生型构象和DNA结合活性,通过这种方式p53的内在不稳定性被中和。缺失C端赋予不稳定性的结构域足以使整个蛋白质的稳定性增强。DnaK与C端结合可在37℃时极大地保护p53免受温度依赖性的DNA结合活性丧失,但不能使变性的p53复性或激活它。相比之下,潜在p53的DNA结合活性的另一种激活剂,单克隆抗体PAb421,它也与该蛋白质的C端相互作用,却不能保护p53免受热变性。两种针对p53 N端的单克隆抗体,PAb1801和DO-1,不会激活p53潜在的DNA结合功能,但可以在37℃时保护p53的野生型构象。因此,p53 DNA结合功能的激活并不等同于免受热变性的保护,所以,这两条途径都可在细胞中用于控制p53的生理活性。通过相互作用蛋白保护p53构象免受热变性提示了一种可在体内调节p53功能的新机制。